Per-Encounter Medical Market Size is valued at USD 121.82 Bn in 2023 and is predicted to reach USD 377.93 Bn by the year 2031 at a 15.38% CAGR during the forecast period for 2024-2031.
Per-encounter medical describes a billing model in which a healthcare practitioner charges a set amount for each patient encounter. This means the patient will always be charged the same amount for each appointment, no matter how long or complicated. This strategy stands in contrast to other payment schemes like capitation and fee-for-service. Under the fee-for-service model, medical professionals charge patients for each treatment they receive. Over a specific period, providers receive a fixed compensation per patient, independent of the number of visits or services provided. Medical billing based on each encounter is common in urgent care centres, walk-in clinics, and treatments requiring regular time and resources.
Furthermore, rising healthcare expenses and an emphasis on value-based care will likely propel the global per-encounter medical industry to steady growth. Payers and providers alike are looking toward pay-for-performance and episode-based payment models to rein in soaring healthcare costs. As a result, more and more people will start paying for each encounter.
However, the market growth is hampered by the high-cost criteria for the safety and health of per-encounter medical and the product's inability to prevent fog in environments with dramatic temperature fluctuations or high humidity per-encounter medical, prices for per-encounter equipment such as syringes, surgical kits, and IV therapy systems are falling due to price pressure from payers, cost-containment initiatives, and unified healthcare systems. Medical device businesses must seek out low-cost manufacturing, regional production, and materials substitution to maintain profit margins. Industry profitability is affected, while market growth is moderated to some extent due to the capacity to charge lower per-unit rates.
The per-encounter medical market is segmented based on product type, application, end-user, and distribution channel. The product type segment is segmented into consumables, devices, software, services, and others. The application segment comprises cardiology, orthopaedics, obstetrics/gynaecology, ophthalmology, gastroenterology, and others. The end-use segment includes hospitals, clinics, diagnostic centres, and others. The distribution channel segment is segmented into direct tender, retail sales, and online sales.
The gastroenterology per-encounter medical market is expected to lead with a major global market share in 2024. A gastroenterologist checks the digestive system for problems, including the smooth passage of food and other substances. Additionally, gastroenterologists are responsible for ensuring normal nutritional digestion and absorption and correctly eliminating waste from the body.
The retail sales industry makes up the bulk of per-encounter medical usage because when retail sales rise, the economy grows well; however, when they fall, it means the reverse. Stock prices tend to rise and benefit shareholders when retail sales increase, especially in countries like the US, Germany, the UK, China, and India.
The North American per-encounter medical market is expected to register the maximum revenue share in the near future. This can be attributed to the area's high rate of chronic diseases, well-developed healthcare system, and welcoming reimbursement rules. In addition, Asia Pacific is estimated to grow rapidly in the global per-encounter medical market due to the growing number of patients, increasing disposable incomes, and better healthcare facilities.
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 121.82 Bn |
|
Revenue Forecast In 2031 |
USD 377.93 Bn |
|
Growth Rate CAGR |
CAGR of 15.38 % from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Product Type, By Application, By End-User, By Distribution Channel |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; Southeast Asia; South Korea |
|
Competitive Landscape |
Abbott, Cardinal Health, Johnson & Johnson, Medtronic, 3M, Steris, Catalent Inc., Smiths Medical Inc., Schott, Nipro Corporation, Terumo Corporation, Gerresheimer AG, Becton, Dickinson and Company, B. Braun Melsungen AG, AngioDynamics Inc., Teleflex Incorporated, Argon Medical Devices, Inc., ICU Medical, Inc., Medical Components, Inc., Vygon (UK) Ltd, Others |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Per-Encounter Medical Market Snapshot
Chapter 4. Global Per-Encounter Medical Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Product Type Estimates & Trend Analysis
5.1. By Product Type, & Market Share, 2019 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Product Type:
5.2.1. Consumables
5.2.2. Devices
5.2.3. Software
5.2.4. Services
5.2.5. Others
Chapter 6. Market Segmentation 2: By Application Estimates & Trend Analysis
6.1. By Application & Market Share, 2019 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Application:
6.2.1. Cardiology
6.2.2. Orthopedics
6.2.3. Obstetrics/Gynecology
6.2.4. Ophthalmology
6.2.5. Gastroenterology
6.2.6. Others
Chapter 7. Market Segmentation 3: By Distribution Channel Estimates & Trend Analysis
7.1. By Distribution Channel & Market Share, 2019 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Distribution Channel:
7.2.1. Direct Tender
7.2.2. Retail Sales
7.2.3. Online Sale
Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis
8.1. By End User & Market Share, 2019 & 2031
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By End User:
8.2.1. Hospitals
8.2.2. Clinics
8.2.3. Diagnostic Centers
8.2.4. Others
Chapter 9. Per-Encounter Medical Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Per-Encounter Medical Market revenue (US$ Million) estimates and forecasts By Product Type, 2024-2031
9.1.2. North America Per-Encounter Medical Market revenue (US$ Million) estimates and forecasts By Application, 2024-2031
9.1.3. North America Per-Encounter Medical Market revenue (US$ Million) estimates and forecasts By Distribution Channel, 2024-2031
9.1.4. North America Per-Encounter Medical Market revenue (US$ Million) estimates and forecasts By End User, 2024-2031
9.1.5. North America Per-Encounter Medical Market revenue (US$ Million) estimates and forecasts by country, 2024-2031
9.2. Europe
9.2.1. Europe Per-Encounter Medical Market revenue (US$ Million) By Product Type, 2024-2031
9.2.2. Europe Per-Encounter Medical Market revenue (US$ Million) By Application, 2024-2031
9.2.3. Europe Per-Encounter Medical Market revenue (US$ Million) By Distribution Channel, 2024-2031
9.2.4. Europe Per-Encounter Medical Market revenue (US$ Million) By End User, 2024-2031
9.2.5. Europe Per-Encounter Medical Market revenue (US$ Million) by country, 2024-2031
9.3. Asia Pacific
9.3.1. Asia Pacific Per-Encounter Medical Market revenue (US$ Million) By Product Type, 2024-2031
9.3.2. Asia Pacific Per-Encounter Medical Market revenue (US$ Million) By Application, 2024-2031
9.3.3. Asia Pacific Per-Encounter Medical Market revenue (US$ Million) By Distribution Channel, 2024-2031
9.3.4. Asia Pacific Per-Encounter Medical Market revenue (US$ Million) By End User, 2024-2031
9.3.5. Asia Pacific Per-Encounter Medical Market revenue (US$ Million) by country, 2024-2031
9.4. Latin America
9.4.1. Latin America Per-Encounter Medical Market revenue (US$ Million) By Product Type, (US$ Million) 2024-2031
9.4.2. Latin America Per-Encounter Medical Market revenue (US$ Million) By Application, (US$ Million) 2024-2031
9.4.3. Latin America Per-Encounter Medical Market revenue (US$ Million) By Distribution Channel, (US$ Million) 2024-2031
9.4.4. Latin America Per-Encounter Medical Market revenue (US$ Million) By End User, (US$ Million) 2024-2031
9.4.5. Latin America Per-Encounter Medical Market revenue (US$ Million) by country, 2024-2031
9.5. Middle East & Africa
9.5.1. Middle East & Africa Per-Encounter Medical Market revenue (US$ Million) By Product Type, (US$ Million) 2024-2031
9.5.2. Middle East & Africa Per-Encounter Medical Market revenue (US$ Million) By Application, (US$ Million) 2024-2031
9.5.3. Middle East & Africa Per-Encounter Medical Market revenue (US$ Million) By Distribution Channel, (US$ Million) 2024-2031
9.5.4. Middle East & Africa Per-Encounter Medical Market revenue (US$ Million) By End User, (US$ Million) 2024-2031
9.5.5. Middle East & Africa Per-Encounter Medical Market revenue (US$ Million) by country, 2024-2031
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Abbott
10.2.2. BD
10.2.3. Cardinal Health
10.2.4. Johnson & Johnson
10.2.5. Medtronic
10.2.6. 3M
10.2.7. Steris
10.2.8. Teleflex
Per-Encounter Medical Market By Product Type-
Per-Encounter Medical Market By Application-
Per-Encounter Medical Market By End-User-
Per-Encounter Medical Market By Distribution Channel-
Per-Encounter Medical Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
